Mind + Muscle

technical minds + legal muscle


dig deep

Reexamination Practice of Biotech/Pharma Patents In Group Art Unit 3991

  • 01.13.10
  • Sterne, Kessler, Goldstein & Fox P.L.L.C.

Today we announced the publication of the first paper to provide an in-depth analysis of patent reexamination in the biotechnology, chemical, and pharmaceutical industries, an increasingly significant patent enforcement source and rapidly developing area of patent litigation practice. To read the full press release click here.

This paper addresses reexamination practice of patents in the Biotechnology/Pharmaceutical arts, specifically Group Art Unit 3991 (AU 3991) of the Central Reexamination Unit (CRU) of the United States Patent and Trademark Office (USPTO). To read the full paper download the PDF above.

Related People

Related Services

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.